Treatment of latent infection to achieve tuberculosis elimination in low-incidence countries.
Jonathon R CampbellDavid DowdyKevin SchwartzmanPublished in: PLoS medicine (2019)
In a Perspective for the Tuberculosis Special Issue, Kevin Schwartzman and colleagues discuss the choices and implications for personal versus public health benefits when pursuing tuberculosis elimination in low-incidence countries.